January 2, 2026 · Form 4 insider transaction
Bjork Elisabeth bought 10,000 shares of Rocket Pharmaceuticals Inc at $3.44 per share, a transaction worth $34.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.